Advanced search
Publication Cover
Leukemia & Lymphoma Volume 56, 2015 - Issue 8
Submit an article Journal homepage
784
Views
10
CrossRef citations to date
0
Altmetric
Review

Novel therapeutic options for relapsed hairy cell leukemia

Preetesh JainDepartment of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USA
,
Aaron PolliackDepartment of Hematology, Hadassah University Hospital, Hebrew University Medical School, Jerusalem, Israel
&
Farhad RavandiDepartment of Leukemia, University of Texas M. D. Anderson Cancer Center, Houston, TX, USACorrespondence[email protected]
Pages 2264-2272 | Received 30 Oct 2014, Accepted 15 Dec 2014, Published online: 04 Feb 2015

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Manli Jiang, N. Nora Bennani & Andrew L. Feldman. (2017) Lymphoma classification update: B-cell non-Hodgkin lymphomas. Expert Review of Hematology 10:5, pages 405-415.
Read now
Michael M. McDowell, Xiao Zhu, Nitin Agarwal, Marina N. Nikiforova, Frank S. Lieberman & Jan Drappatz. (2016) Response of relapsed central nervous system hairy cell leukemia to vemurafenib. Leukemia & Lymphoma 57:12, pages 2952-2954.
Read now

Articles from other publishers (8)

L.S. Al-Radi, Svetlana Yurevna Smirnova, T.N. Moiseeva, I.S. Piskunova, L.V. Plastinina, D.V. Novikova, E.G. Gemdzhian & G.M. Galstyan. (2022) Experience with the Use of B-RAF Inhibitor Vemurafenib in the Treatment of Hairy Cell Leukemia. Clinical oncohematology 15:4, pages 349-355.
Crossref
Svetlana Yu. Smirnova, Lyubov S. Al-Radi, Tatyana N. Moiseeva, Eduard G. Gemdzhian, Igor A. Yakutik, Hunan L. Julhakyan, Vyacheslav A. Novikov, Gennady M. Galstyan & Andrey B. Sudarikov. (2021) Inhibitor of BRAFV600E Mutation as a Treatment Option for Hairy Cell Leukemia With Deep Neutropenia and Infectious Complications. Clinical Lymphoma Myeloma and Leukemia 21:7, pages 427-430.
Crossref
Narendranath Epperla, Melissa Pavilack, Temitope Olufade, Richa Bashyal, Jieni Li, Shaum M. Kabadi, Huseyin Yuce & Leslie Andritsos. (2020) Adverse event rates and economic burden associated with purine nucleoside analogs in patients with hairy cell leukemia: a US population-retrospective claims analysis. Orphanet Journal of Rare Diseases 15:1.
Crossref
Karen M Fancher & Zachary C Lally-Montgomery. (2019) Moxetumomab pasudotox: A first-in-class treatment for hairy cell leukemia. Journal of Oncology Pharmacy Practice 25:6, pages 1467-1472.
Crossref
Daniel P. ShenoiLeslie A. Andritsos, James S. Blachly, Kerry A. Rogers, Mollie E. Moran, Mirela Anghelina, Jeffrey A. Jones & Michael R. Grever. (2019) Classic hairy cell leukemia complicated by pancytopenia and severe infection: a report of 3 cases treated with vemurafenib. Blood Advances 3:2, pages 116-118.
Crossref
C.I. Edvard Smith. (2017) Enigmas in tumor resistance to kinase inhibitors and calculation of the drug resistance index for cancer (DRIC). Seminars in Cancer Biology 45, pages 36-49.
Crossref
Jacqueline M Cortazar, Daniel J DeAngelo, Geraldine S Pinkus & Elizabeth A Morgan. (2017) Morphological and immunophenotypical features of hairy cell leukaemia involving lymph nodes and extranodal tissues. Histopathology 71:1, pages 112-124.
Crossref
RG Mihaila. (2015) Are Cladribine and Rituximab Enough for the Treatment of Relapsed Hairy Cell Leukemia?. International Journal of Immunotherapy and Cancer Research, pages 004-007.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.